SCHEMBL982269

SCHEMBL982269

[CH2]S(=O)(=O)CC=C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2016950 0.74 CA2 (0.32)
Diallylsulfone SCHEMBL9947 0.74
SCHEMBL170596 0.73
SCHEMBL3351890 0.71
Diallylsulfone SCHEMBL9518459 0.71 CA2 (0.31)
Diallylsulfone SCHEMBL17707262 0.71 CA2 (0.31)
SCHEMBL13609 0.71
Diallylsulfone SCHEMBL27610318 0.71
SCHEMBL12274522 0.69
SCHEMBL11648838 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 294 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024146922-A1 C5AR1 INHIBITORS FOR USE IN THE TREATMENT OF OCULAR MUCOUS MEMBRANE PEMPHIGOID AND/OR ORAL MUCOUS MEMBRANE PEMPHIGOID DOMPE' FARMACEUTICI SPA (IT) 2024-07-11 WO claimed
EP-4397306-A1 C5AR1 INHIBITORS FOR USE IN THE TREATMENT OF OCULAR MUCOUS MEMBRANE PEMPHIGOID AND/OR ORAL MUCOUS MEMBRANE PEMPHIGOID Dompe' Farmaceutici S.P.A. (IT) 2024-07-10 EP claimed
US-20240180888-A1 C5AR1 INHIBITORS FOR TREATING HYPERSENSITIVITY REACTIONS TO TAXANES DOMPE' FARMACEUTICI SPA (IT) 2024-06-06 US claimed
EP-4308114-A1 C5AR1 INHIBITORS FOR TREATING HYPERSENSITIVITY REACTIONS TO TAXANES Dompe' Farmaceutici SpA (IT) 2024-01-24 EP claimed
US-20200397725-A1 C5AR INHIBITORS FOR USE IN THE TREATMENT OF CHEMOTHERAPY-INDUCED IATROGENIC PAIN DOMPE' FARMACEUTICI S.P.A. (IT) 2020-12-24 US claimed
EP-3723744-A2 C5AR INHIBITORS FOR USE IN THE TREATMENT OF CHEMOTHERAPY-INDUCED IATROGENIC PAIN Dompé farmaceutici S.p.A. (IT) 2020-10-21 EP claimed
WO-2019115493-A2 C5AR INHIBITORS FOR USE IN THE TREATMENT OF CHEMOTHERAPY-INDUCED IATROGENIC PAIN DOMPE' FARMACEUTICI S.P.A. (IT) 2019-06-20 WO claimed
EP-3498269-A1 C5AR INHIBITORS FOR USE IN THE TREATMENT OF CHEMOTHERAPY-INDUCED IATROGENIC PAIN Dompé farmaceutici S.p.A. (IT) 2019-06-19 EP claimed
US-9203113-B2 Nonaqueous electrolyte solution, electrochemical element using same, and 1,2-dioxypropane compound used in same UBE INDUSTRIES, LTD. (JP) 2015-12-01 US claimed
CN-102782927-B Nonaqueous electrolyte solution, electrochemical element using same, and 1,2-dioxypropane compound used in same UBE INDUSTRIES 2015-07-15 CN claimed
EP-0827505-A1 SELECTED SOLUBLE ESTERS OF HYDROXYL-CONTAINING INDOLOCARBAZOLES CEPHALON, INC. (US) 1998-03-11 EP claimed
US-5686444-A Selected soluble esters of hydroxyl-containing indolocarbazoles CEPHALON, INC. (US) 1997-11-11 US claimed
US-5650407-A TREATING PROSTATE DISEASES CEPHALON, INC. (US) 1997-07-22 US claimed
WO-1996031515-A1 SELECTED SOLUBLE ESTERS OF HYDROXYL-CONTAINING INDOLOCARBAZOLES CEPHALON, INC. (US) 1996-10-10 WO claimed
EP-0298680-B1 HERBICIDAL COMPOSITIONS OF ACYLATED 1,3-DICARBONYL HERBICIDES AND ANTIDOTES THEREFOR ZENECA INC. (US) 1993-09-15 EP claimed
CN-1057837-A 2-benzo [C] furanone and heterocycle 2-benzo [C] furanone that replace SANDOZ LTD (CH) 1992-01-15 CN claimed
EP-0351676-A2 Benzothiazolones NIHON BAYER AGROCHEM K.K. (JP) 1990-01-24 EP claimed
US-4831032-A CARDIOVASCULAR DISORDERS, HYPOTENSIVE, ISOTROPIC AGENTS BOEHRINGER MANNHEIM GMBH (DE) 1989-05-16 US claimed
EP-0298680-A2 Herbicidal compositions of acylated 1,3-dicarbonyl herbicides and antidotes therefor ZENECA INC. (US) 1989-01-11 EP claimed
EP-0277292-A1 Organic solvent-free process for preparing pyrimidinyl organophosphates THE DOW CHEMICAL COMPANY (US) 1988-08-10 EP claimed